scholarly article | Q13442814 |
P2093 | author name string | Richard J Smeyne | |
Yun Jiao | |||
Justin D Boyd | |||
Kennie R Shepherd | |||
Sally Slack | |||
Haeman Jang | |||
Ciaran Faherty | |||
P2860 | cites work | Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+ | Q68821467 |
The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice | Q69431808 | ||
Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice | Q69897497 | ||
Studies on the melanin affinity of selegiline (deprenyl) and other amphetamine derivatives | Q70375249 | ||
MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice | Q70839418 | ||
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q70951248 | ||
Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics | Q73854145 | ||
Parkinson's disease, pesticides, and glutathione transferase polymorphisms | Q22004263 | ||
Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus | Q28208902 | ||
Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata | Q28377237 | ||
Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases | Q28508252 | ||
Parkinson's disease: mechanisms and models | Q29547424 | ||
Etiology and pathogenesis of Parkinson's disease | Q33593402 | ||
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease | Q33943273 | ||
Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism | Q33985962 | ||
alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells | Q34109337 | ||
The last decade in Parkinson's disease research. Basic sciences | Q34366792 | ||
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration | Q34983386 | ||
Neuroinflammatory processes in Parkinson's disease. | Q35094887 | ||
COX-2 and neurodegeneration in Parkinson's disease. | Q35171052 | ||
GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism | Q35616756 | ||
Recent advances in research on Parkinson disease: synuclein and parkin | Q35681283 | ||
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease | Q35736273 | ||
The MPTP model of Parkinson's disease | Q36080019 | ||
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. | Q40553539 | ||
MPTP, MPP+ and mitochondrial function | Q41382377 | ||
Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. | Q42468902 | ||
Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. | Q42471915 | ||
Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline | Q43804325 | ||
The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease | Q44148987 | ||
Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress | Q44597471 | ||
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease | Q44740801 | ||
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain | Q45256207 | ||
Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. | Q45944012 | ||
Glia cell number modulates sensitivity to MPTP in mice | Q46514011 | ||
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice | Q48139523 | ||
Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice | Q48151484 | ||
The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals | Q48407639 | ||
Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources | Q48444205 | ||
Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. | Q48478164 | ||
Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice | Q48542762 | ||
Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. | Q48631699 | ||
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase | Q48681443 | ||
Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity | Q49124162 | ||
In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. | Q51406427 | ||
MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. | Q53900769 | ||
Genetics of Parkinson's disease | Q67218920 | ||
Epidemiology of Parkinson's disease. | Q67401761 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | substantia nigra | Q753278 |
P1104 | number of pages | 10 | |
P304 | page(s) | 107-116 | |
P577 | publication date | 2007-08-09 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta | |
P478 | volume | 1175 |